In the later stage of MM, the programmed cell death protein-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) expressions on the T-cell surface increase, and the quantity and quality of T-cells decrease [1, 2, 25]. Here, PDCD1 is linked to Miyoshi myopathy.